Lu-177 DOTATATE Therapy / PRRT

यह Therapy क्या है

A somatostatin-analogue carrier delivers lutetium-177 radiation to tumour cells expressing suitable receptors. “Lu-177 DOTA therapy” is a related search term; the specialist confirms the actual treatment.

Assessment के लिए किन Patients को Consider किया जा सकता है

Patients with selected neuroendocrine tumours may be referred after receptor imaging and multidisciplinary review.

Specialists Suitability कैसे Assess करते हैं

Specialists review receptor expression, tumour type and distribution, prior treatments, blood counts, kidney and liver function and care goals.

कौनसे Scans और Reports Review हो सकते हैं

• DOTATATE or DOTANOC PET-CT
• Histopathology
• Prior imaging
• Treatment summary
• Recent blood, kidney and liver tests

Diagnostic imaging and radionuclide therapy are different services. The treating specialist decides which scans and reports are required.

Treatment Process कैसे चलता है

1. 1Referral and receptor-imaging review
2. 2Laboratory and clinical assessment
3. 3Centre planning and kidney-protection protocol
4. 4Licensed-centre administration
5. 5Planned follow-up and cycle review

Preparation की जानकारी

The centre may provide fasting, hydration, medicines and amino-acid infusion instructions. These are patient- and centre-specific.

Outpatient Treatment या Admission

Treatment may be outpatient or require observation/admission depending on centre protocol, patient condition and radiation-safety requirements.

Possible Side Effects और Precautions

Nausea, fatigue, temporary blood-count changes and kidney-related risks may be discussed. Individual precautions come from the treating team.

Follow-up और Monitoring

Blood counts, kidney/liver function, symptoms and imaging may be reviewed before later cycles and during follow-up.

Related Diagnostic Scans देखें

A linked scan is not automatically required for treatment. Follow the treating specialist’s advice.